Lonneke A. van Vught

Academic Medical Center — Netherlands

Medicine · Health Sciences

44h-index8.5kcitations140works7.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sepsis Diagnosis and Treatment(63), COVID-19 Clinical Research Studies(25), SARS-CoV-2 and COVID-19 Research(22), Intensive Care Unit Cognitive Disorders(18), Nosocomial Infections in ICU(16)

Publications121 total

Implementing a sepsis prediction score in out-of-hours primary care: Feasibility and acceptability study
European Journal of General Practice·2025Open Access
The immunology of sepsis: translating new insights into clinical practice
Nature Reviews Nephrology·2025· 7 cited
A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patients
Intensive Care Medicine Experimental·2025Open Access
Pathogen-specific host response in critically ill patients with blood stream infections: a nested case–control study
EBioMedicine·2025· 4 citedOpen Access
Host Response Protein Biomarkers Indicative of Persistent Acute Kidney Injury in Critically Ill COVID-19 Patients
Critical Care Explorations·2025Open Access
Clinical subtypes in critically ill patients with sepsis: validation and parsimonious classifier model development
Critical Care·2025· 10 citedOpen Access
Temporal Transitions of the Hyperinflammatory and Hypoinflammatory Phenotypes in Critical Illness
American Journal of Respiratory and Critical Care Medicine·2024· 25 citedOpen Access
Clinical Subtype Trajectories in Sepsis Patients Admitted to the ICU: A Secondary Analysis of an Observational Study
Critical Care Explorations·2024· 6 citedOpen Access
Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19
Intensive Care Medicine·2024· 20 citedOpen Access
Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial
Critical Care·2024· 6 citedOpen Access
Towards personalized medicine: a scoping review of immunotherapy in sepsis
Critical Care·2024· 39 citedOpen Access
Biomarker patterns in patients with cardiogenic shock versus septic shock
IJC Heart & Vasculature·2024· 3 citedOpen Access
Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study
Critical Care·2024· 3 citedOpen Access
Dynamic Transitions of the Hyperinflammatory and Hypoinflammatory Subphenotypes in Critical Illness: Implications for Clinical Outcomes
2024
The effect of immunosuppressive therapies on the endothelial host response in critically ill COVID-19 patients
Scientific Reports·2024· 4 citedOpen Access
Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study
Annals of Intensive Care·2024· 7 citedOpen Access
Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis
Annals of Hepatology·2024· 5 citedOpen Access
Biomarker Analysis Provides Evidence for Host Response Homogeneity in Patients With COVID-19
CHEST Critical Care·2024· 3 citedOpen Access
Pathogen-Specific Host Response in Critically Ill Patients with Blood Stream Infections
SSRN Electronic Journal·2024Open Access
Subphenotypes in critical illness: a priori biological rationale is key
Intensive Care Medicine·2023· 3 cited
page 1 of 7Next →

Frequent Co-authors

Tom van der Poll(41), Marcus J. Schultz(34), Janneke Horn(30), Olaf L. Cremer(28), Brendon P. Scicluna(27), Marc J. M. Bonten(26), Maryse A. Wiewel(24), Arie J. Hoogendijk(22), Peter M. C. Klein Klouwenberg(18), Lieuwe D. J. Bos(17), David S. Y. Ong(16), Aeilko H. Zwinderman(12), Jos F. Frencken(12), Alexander P. J. Vlaar(12), Laura R. A. Schouten(10), Peter Nürnberg(9), Friso M. de Beer(9), Marleen Straat(9), Luuk Wieske(9), W. Joost Wiersinga(9)